MarketBeat reported on stock consensus ratings, while Decoy Therapeutics announced a partnership with Fox Chase Cancer Center.
1 report, 1 independent
Updated Jun 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat reported on stock consensus ratings, while Decoy Therapeutics announced a partnership with Fox Chase Cancer Center.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Fox Chase Cancer Center
research facility and hospital, United States
Nothing else this week.
Related events
- MarketBeat provides stock rating data for Vivos Therapeutics, which is listed on Nasdaq.
- Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.
- MarketBeat provided analyst ratings and targets for small-cap healthcare companies Emergent BioSolutions and Entrada Therapeutics.
- MarketBeat reported on the stock performance of Allarity Therapeutics, Inc. on September 1, 2026.
- MarketBeat summarized current ratings and price targets for Arcturus Therapeutics.